UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.410-415

2014

Link zum Volltext

Verfügbarkeit prüfen

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (6), p.445-451

2006

Link zum Volltext

Verfügbarkeit prüfen

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 (6), p.790-794

2015

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.1919-1928

2021

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Bone marrow transplantation (Basingstoke), 2009-07, Vol.44 (1), p.27-33

2009

Link zum Volltext

Verfügbarkeit prüfen

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

Bone marrow transplantation (Basingstoke), 1997-12, Vol.20 (12), p.1075-1080

1997

Link zum Volltext

Verfügbarkeit prüfen

Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1489-1496

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.787-797

2019

Link zum Volltext

Verfügbarkeit prüfen

Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?

Bone marrow transplantation (Basingstoke), 2010-09, Vol.45 (9), p.1379-1387

2010

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Bone marrow transplantation (Basingstoke), 2019-01, Vol.54 (1), p.44-52

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

Bone marrow transplantation (Basingstoke), 2016-11, Vol.51 (11), p.1456-1463

2016

Link zum Volltext

Verfügbarkeit prüfen

TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions

Bone marrow transplantation (Basingstoke), 2011-04, Vol.46 (4), p.475-484

2011

Link zum Volltext

Verfügbarkeit prüfen

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

Bone marrow transplantation (Basingstoke), 2007-10, Vol.40 (7), p.633-642

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

Bone marrow transplantation (Basingstoke), 2018-05, Vol.53 (5), p.617-624

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Link zum Volltext

Verfügbarkeit prüfen

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Bone marrow transplantation (Basingstoke), 2016-12, Vol.51 (12), p.1573-1578

2016

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Bone marrow transplantation (Basingstoke), 2022-04, Vol.57 (4), p.627-632

2022

Link zum Volltext

Verfügbarkeit prüfen

Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.941-949

2017

Link zum Volltext

Verfügbarkeit prüfen

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Bone marrow transplantation (Basingstoke), 2020-12, Vol.55 (12), p.2335-2338

2020

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Bone marrow transplantation (Basingstoke), 2016-05, Vol.51 (5), p.654-662

2016

Link zum Volltext

Verfügbarkeit prüfen

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

Bone marrow transplantation (Basingstoke), 2010-09, Vol.45 (9), p.1442-1448

2010

Link zum Volltext

Verfügbarkeit prüfen

Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?

Bone marrow transplantation (Basingstoke), 2015-11, Vol.50 (11), p.1393-1404

2015

Link zum Volltext

Verfügbarkeit prüfen

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia

Bone marrow transplantation (Basingstoke), 2010-10, Vol.45 (10), p.1479-1488

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBone Marrow Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Stem Cell Transplantation
(65)
Biophysics
(55)
Hematology
(55)
Immunology
(55)
Life Sciences & Biomedicine
(55)
Oncology
(55)
Science & Technology
(55)
Transplantation
(55)
Humans
(49)
Care And Treatment
(41)
Bone Marrow
(40)
Stem Cells
(35)
Adult
(34)
Middle Aged
(30)
Lymphoma
(29)
Biological And Medical Sciences
(27)
Female
(27)
Medical Sciences
(27)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(26)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(26)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The International Journal Of Developmental Biology
(1)

Menü

Weitere Dienste

Einstellungen

ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma

Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications

Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?

The role of stem cell transplantation in the management of relapsed follicular lymphoma in the era of targeted therapies

Hematopoietic SCT for mantle cell lymphoma: is it the standard of care?

Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning

TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions

Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders

Bendamustine-EAM versus BEAM regimen in patients with mantle cell lymphoma undergoing autologous stem cell transplantation in the frontline setting: a multicenter retrospective study from Lymphoma Study Association (LYSA) centers

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia

Aktive Filter

Suchergebnisse filtern